Press Release
Analyst Call Recording
Analyst Call Transcripts
Investor Presentation
Financial Results
Standalone Audited Financials
Email Subscription Centre
Subsidiaries' Financials FY23-24
| Company Name | Financial Report |
|---|---|
| Cult Health, LLC | AR - FR 2023 - 2024 |
| DT Associates Research and Consulting, Inc, | AR - FR 2023 - 2024 |
| DT Associates Research and Consulting Services Ltd | AR - FR 2023 - 2024 |
| ILSL Holdings, Inc. | AR - FR 2023 - 2024 |
| Indegene Europe LLC | AR - FR 2023 - 2024 |
| Indegene Fareast Pte, Ltd. | AR - FR 2023 - 2024 |
| Indegene Healthcare Germany GmbH | AR - FR 2023 – 2024 |
| Indegene Healthcare Mexico S DE RL DE CV | AR - FR 2023 - 2024 |
| Indegene Healthcare UK Limited | AR - FR 2023 - 2024 |
| Indegene, Inc. | AR - FR 2023 – 2024 |
| Indegene Ireland Limited | AR - FR 2023 – 2024 |
| Indegene Japan, LLC | AR - FR 2023 – 2024 |
| Indegene Lifesystems Consulting (Shanghai) Co. Ltd. | AR - FR 2023 – 2024 |
| Services Indegene Aptilon, Inc. | AR - FR 2023 – 2024 |
The Company acquired Trilogy Writing & Consulting GmbH, Trilogy Writing & Consulting, Inc.Trilogy Writing & Consulting Limited and Trilogy Writing & Consulting ULC on 22 March 2024. However, their financial year is from 1 January to 31 December. Therefore, the Company does not have any audited / unaudited financial statements for the year ended 31 March 2024.
Earlier year Subsidiaries' Financials
| Company Name | Financial Report |
|---|---|
| ILSL Holdings, Inc. | Audited Financials FY22-23 |
| ILSL Holdings, Inc. | Audited Financials FY2021-22, FY2020-21 and FY2019-20 |
| Indegene, Inc. | Audited Financials FY2022-23 |
| Indegene, Inc. | Audited Financials FY2021-22, FY2020-21 and FY2019-20 |